21070 results for «»
21070 results
Coronary microvascular dysfunction in case examples: invisible, measurable, treatable
18 May 2022 – From EuroPCR 2022
In this very practical session from EuroPCR 2022 focusing on microcirculation, learn how to perform a step-by-step assessment of the coronary microcirculation in the cathlab, discuss the whole management of patients with coronary microvascular dysfunction (CMD), and understand how to use coronary flow reserve (CFR) and index...
Is PCI enough in STEMI?
18 May 2022 – From EuroPCR 2022
With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct...
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial
01 Jun 2022
The present study aimed at investigating a potential reduction of the HF hospitalization rate between 1 and 2 years after inclusion in the MITRA-FR trial.
Reviewer
Reviewer
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
First dedicated transcatheter leaflet splitting device from bench to first-in-man
20 May 2022 – From EuroPCR 2022
Pierre Deharo interviews Didier Tchétché on the first transcatheter leaflet splitting device (ShortCut device)which can be targeted for bicuspid aortic valves and valve-in-valve procedures.
Transcatheter tricuspid valve repair: CLASP TR study one-year results
19 May 2022 – From EuroPCR 2022
Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.
Prevention of radial artery occlusion of 3 hemostatic methods in transradial intervention for coronary angiography
01 Jun 2022
The main objective of the PROTHECT (Prevention of Radial artery Occlusion of Three HEmostatiC methods in Transradial intervention for coronary angiography) trial was to compare the efficacy of 3 nonocclusive haemostatic methods in preventing early RAO2.
Reviewer
Abbreviated DAPT after complex PCI in high bleeding risk patients
18 May 2022 – From EuroPCR 2022
Luis Ortega Paz interviews Pascal Vranckx on the background, main results and take-home messages from the sub-analysis of the MASTER DAPT study.
Hypertension management in 2022: Latest data on renal denervation
17 May 2022 – From EuroPCR 2022
Ali Nazmi Calik discusses with David Kandzari the current data on the catheter-based renal denervation treatment to reduce blood pressure in patients with hypertension. They discuss more specifically the results from SPYRAL HTN-ON MED 3-year data, the 3-year Global SYMPLICITY Registry and RADIANCE-HTN SOLO and TRIO...
DIStal vs. COnventional RADIAL access for coronary angiography and intervention - the DISCO Radial Trial
18 May 2022 – From EuroPCR 2022
David Rodrigues interviews Adel Aminian on the results from the DISCO Radial trial. This is the first large-scale multicenter randomized evidence comparing DRA to TRA in patients scheduled for coronary angiography or PCI with respect to the incidence of RAO at discharge.
JenaValve Trilogy for treatment of aortic regurgitation: worldwide first results
18 May 2022 – From EuroPCR 2022
Alexander Tamm shares with Alessandro Sticchi the results of the JenaValve Trilogy study, the first experience of implantation of the JenaValve device for treating aortic regurgitation.
Mara Pilati
Rome, Italy
Gianfranco Butera
Rome, Italy
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study
02 Jun 2022
State-of-the-art imaging for structural heart disease interventions
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to focus on imaging and help understand what imaging has changed in recent years: learn how to perform pre-procedural planning and how advanced imaging can make procedures easier and safer.
Matthew J. Gillespie
Philadelphia, United States of America
Robotic PCI: evolution or R-Evolution
19 May 2022 – From EuroPCR 2022
Consult this session including a recorded case, and learn more about robotic PCI - its benefits and recent clinical results. Discover what might be the future of robotic PCI.
The PCR Tricuspid Focus Group at EuroPCR 2022
02 Jun 2022
During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.
Cracking calcium: best practices to integrate intravascular lithotripsy (IVL) into your calcium management algorithms
19 May 2022 – From EuroPCR 2022
Consult this session to learn about the best practices and tips to optimise application of intravascular lithotripsy (IVL) in coronary vasculature, and to discover some new calcium management algorithms to improve PCI outcomes as well as the latest technological advancements of peripheral IVL for pre-TAVI access.
